SG11202110646PA - A subunit vaccine for treatment or prevention of a respiratory tract infection - Google Patents
A subunit vaccine for treatment or prevention of a respiratory tract infectionInfo
- Publication number
- SG11202110646PA SG11202110646PA SG11202110646PA SG11202110646PA SG11202110646PA SG 11202110646P A SG11202110646P A SG 11202110646PA SG 11202110646P A SG11202110646P A SG 11202110646PA SG 11202110646P A SG11202110646P A SG 11202110646PA SG 11202110646P A SG11202110646P A SG 11202110646PA
- Authority
- SG
- Singapore
- Prior art keywords
- prevention
- treatment
- respiratory tract
- tract infection
- subunit vaccine
- Prior art date
Links
- 206010057190 Respiratory tract infections Diseases 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 229940031626 subunit vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/115—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18311—Metapneumovirus, e.g. avian pneumovirus
- C12N2760/18322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18311—Metapneumovirus, e.g. avian pneumovirus
- C12N2760/18334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19175413 | 2019-05-20 | ||
| PCT/EP2020/063973 WO2020234300A1 (en) | 2019-05-20 | 2020-05-19 | A subunit vaccine for treatment or prevention of a respiratory tract infection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202110646PA true SG11202110646PA (en) | 2021-10-28 |
Family
ID=66685352
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202110646PA SG11202110646PA (en) | 2019-05-20 | 2020-05-19 | A subunit vaccine for treatment or prevention of a respiratory tract infection |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US20220185847A1 (ko) |
| EP (1) | EP3972639A1 (ko) |
| JP (1) | JP2022533318A (ko) |
| KR (1) | KR20220010478A (ko) |
| CN (1) | CN114127101A (ko) |
| AU (1) | AU2020277661A1 (ko) |
| BR (1) | BR112021021637A2 (ko) |
| CA (1) | CA3138064A1 (ko) |
| CL (1) | CL2021002819A1 (ko) |
| CO (1) | CO2021014694A2 (ko) |
| EC (1) | ECSP21079178A (ko) |
| GB (1) | GB2598494A (ko) |
| IL (1) | IL287099A (ko) |
| MX (1) | MX2021013111A (ko) |
| PE (1) | PE20220400A1 (ko) |
| SG (1) | SG11202110646PA (ko) |
| WO (1) | WO2020234300A1 (ko) |
| ZA (1) | ZA202106883B (ko) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3174599A1 (en) | 2020-04-09 | 2021-10-14 | Robert Schlegl | Improvements in vaccine formulations for medical use |
| MX2023004078A (es) | 2020-10-09 | 2023-05-24 | Univ Texas | Proteinas f de hmpv estabilizadas por prefusion. |
| KR20230107621A (ko) | 2020-11-13 | 2023-07-17 | 아이코사백스, 인크. | 메타뉴모바이러스에 대한 단백질-기반 나노입자 백신 |
| EP4319804A2 (en) | 2021-04-09 | 2024-02-14 | Valneva SE | Human metapneumo virus vaccine |
| WO2023110618A1 (en) * | 2021-12-16 | 2023-06-22 | Janssen Vaccines & Prevention B.V. | Stabilized pre-fusion hmpv fusion proteins |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1167379A3 (en) | 1994-07-15 | 2004-09-08 | University Of Iowa Research Foundation | Immunomodulatory oligonucleotides |
| AT408721B (de) | 1999-10-01 | 2002-02-25 | Cistem Biotechnologies Gmbh | Pharmazeutische zusammensetzung enthaltend ein antigen |
| AT409085B (de) | 2000-01-28 | 2002-05-27 | Cistem Biotechnologies Gmbh | Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen |
| AT410173B (de) | 2000-06-08 | 2003-02-25 | Cistem Biotechnologies Gmbh | Antigene zusammensetzung |
| DK1296713T3 (da) | 2000-06-08 | 2004-01-26 | Intercell Biomedizinische Forschungs & Entwicklungs Gmbh | Immunstimulerende oligodeoxynukleotider |
| CA2418854A1 (en) | 2000-08-17 | 2002-02-21 | Jorg Fritz | A vaccine which comprises at least one antigen and a cathelididin derived antimicrobial peptide or a derivative thereof |
| AT410635B (de) | 2000-10-18 | 2003-06-25 | Cistem Biotechnologies Gmbh | Vakzin-zusammensetzung |
| US8715922B2 (en) * | 2001-01-19 | 2014-05-06 | ViroNovative | Virus causing respiratory tract illness in susceptible mammals |
| WO2002095027A2 (en) | 2001-05-21 | 2002-11-28 | Intercell Ag | Immunostimulatory oligodeoxynucleic molecules |
| AU2002358616A1 (en) | 2001-12-07 | 2003-06-17 | Intercell Ag | Immunostimulatory oligodeoxynucleotides |
| DE602004029657D1 (de) | 2003-03-24 | 2010-12-02 | Intercell Ag | Verbesserte impfstoffe |
| US7704720B2 (en) * | 2003-04-25 | 2010-04-27 | Medimmune, Llc | Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus |
| DK3785730T3 (da) | 2011-12-06 | 2024-05-06 | Valneva Austria Gmbh | Aluminiumforbindelser til anvendelse i terapeutiske produkter og vacciner |
| EP3236998A1 (en) * | 2014-12-24 | 2017-11-01 | The U.S.A. as represented by the Secretary, Department of Health and Human Services | Recombinant metapneumovirus f proteins and their use |
| WO2019092002A1 (en) * | 2017-11-07 | 2019-05-16 | Valneva Se | Pharmaceutical compositions for treatment or prevention of viral infections |
-
2020
- 2020-05-19 SG SG11202110646PA patent/SG11202110646PA/en unknown
- 2020-05-19 KR KR1020217034461A patent/KR20220010478A/ko unknown
- 2020-05-19 AU AU2020277661A patent/AU2020277661A1/en active Pending
- 2020-05-19 JP JP2021564088A patent/JP2022533318A/ja active Pending
- 2020-05-19 WO PCT/EP2020/063973 patent/WO2020234300A1/en active Application Filing
- 2020-05-19 PE PE2021001766A patent/PE20220400A1/es unknown
- 2020-05-19 CA CA3138064A patent/CA3138064A1/en active Pending
- 2020-05-19 GB GB2114836.6A patent/GB2598494A/en active Pending
- 2020-05-19 MX MX2021013111A patent/MX2021013111A/es unknown
- 2020-05-19 US US17/606,811 patent/US20220185847A1/en active Pending
- 2020-05-19 EP EP20726137.1A patent/EP3972639A1/en active Pending
- 2020-05-19 BR BR112021021637A patent/BR112021021637A2/pt unknown
- 2020-05-19 CN CN202080030901.9A patent/CN114127101A/zh active Pending
-
2021
- 2021-09-17 ZA ZA2021/06883A patent/ZA202106883B/en unknown
- 2021-10-07 IL IL287099A patent/IL287099A/en unknown
- 2021-10-25 EC ECSENADI202179178A patent/ECSP21079178A/es unknown
- 2021-10-26 CL CL2021002819A patent/CL2021002819A1/es unknown
- 2021-10-29 CO CONC2021/0014694A patent/CO2021014694A2/es unknown
-
2023
- 2023-10-24 US US18/493,004 patent/US20240067681A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20220010478A (ko) | 2022-01-25 |
| MX2021013111A (es) | 2021-11-17 |
| CL2021002819A1 (es) | 2022-07-08 |
| US20240067681A1 (en) | 2024-02-29 |
| AU2020277661A1 (en) | 2021-10-21 |
| EP3972639A1 (en) | 2022-03-30 |
| BR112021021637A2 (pt) | 2021-12-21 |
| JP2022533318A (ja) | 2022-07-22 |
| CA3138064A1 (en) | 2020-11-26 |
| ZA202106883B (en) | 2022-07-27 |
| ECSP21079178A (es) | 2021-11-30 |
| CN114127101A (zh) | 2022-03-01 |
| PE20220400A1 (es) | 2022-03-22 |
| WO2020234300A1 (en) | 2020-11-26 |
| GB202114836D0 (en) | 2021-12-01 |
| US20220185847A1 (en) | 2022-06-16 |
| GB2598494A (en) | 2022-03-02 |
| IL287099A (en) | 2021-12-01 |
| CO2021014694A2 (es) | 2022-01-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL287099A (en) | Subunit vaccine for the treatment and prevention of inflammatory diseases of the respiratory system | |
| IL262104A (en) | A mouthpiece for cooling a patient's oral tissue during therapeutic treatment | |
| IL287423A (en) | Antibodies and methods for treating influenza E infection | |
| HUE058250T2 (hu) | Gyógyszer rhinovírus-fertõzés megelõzésére vagy kezelésére | |
| IL268127A (en) | Preparations containing adrevan for oral or gastric administration and their use for treatment | |
| PL3307293T3 (pl) | Preparaty do leczenia zaburzeń jamy ustnej, gardła i dróg oddechowych | |
| EP4146340A4 (en) | INHALED STATINS FOR THE TREATMENT OF VIRAL RESPIRATORY DISEASES | |
| EP4121084A4 (en) | COMPOSITIONS FOR THE TREATMENT OF RESPIRATORY TRACT INFECTION AND THEIR USES | |
| GB201912059D0 (en) | Combaination therapy of a patient subgroup | |
| GB202007404D0 (en) | Treatment for viral respiratory infections | |
| GB202015584D0 (en) | Treatment for viral infection | |
| EP4119163A4 (en) | THERAPEUTIC AGENT FOR VIRUS INFECTIONS | |
| EP4121038A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CORONAVIRUS INFECTION AND RESPIRATORY COMPROMISE | |
| IL272562B1 (en) | Compounds or pharmaceutically acceptable salts thereof for the treatment of mycobacterial infection | |
| AU2022410715A1 (en) | Pharmaceutical combination for the treatment of the respiratory infection caused by sars-cov-2 | |
| IL290752A (en) | Preparations and methods for treating influenza infection a | |
| IL310974A (en) | Prevention of lower respiratory tract infection with NIRSEVIMAB | |
| ZA201907779B (en) | Fabric for preventing/treating upper respiratory tract infection | |
| IL275152A (en) | System for hypothermia treatment of a patient | |
| GB202110146D0 (en) | Treatment of respiratory conditions | |
| GB202004452D0 (en) | Respiratory treatment device | |
| EP4129291A4 (en) | CORONAVIRUS INFECTION TREATMENT MEDICATION | |
| AU2017905124A0 (en) | Treatment of respiratory infection (2) | |
| AU2017901180A0 (en) | Treatment of respiratory infection | |
| GB202312455D0 (en) | A vaccine for the treatment or prevention of Burkholderia species infection in a subject. |